From Patient
to possibility
Restoring hope through a fundamentally new approach to treating neurodegenerative diseases
Revalesio is a clinical-stage pharmaceutical company with a vision to develop safe and effective treatments for people with neurological diseases. Our pioneering science and nanotechnology address fundamental disease mechanisms to provide neuroprotection and thereby slow disease progression and improve quality of life.
Unique
Nanotechnology
Our proprietary technology applies physics to create a new class of drugs
Promising
Pipeline
Our lead candidate, RNS60, is rapidly advancing in clinical programs in amyotrophic lateral sclerosis (ALS) and ischemic stroke
Career
Opportunities
Join us in our effort to improve the lives of millions